About Hôpital Claude Huriez
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
University Hospital, Lille
101
The Lymphoma Academic Research Organisation
27
Celgene
24
Hoffmann-La Roche
15
Janssen Research & Development, LLC
14
Pfizer
14
Groupe Francophone des Myelodysplasies
13
Gilead Sciences
11
Hospices Civils de Lyon
10
Amgen
8
Federation Francophone de Cancerologie Digestive
8
Clinical Trials at Hôpital Claude Huriez
During the past decade, Hôpital Claude Huriez conducted 280 clinical trials. In the 10-year time frame, 280 clinical trials started and 78 clinical trials were completed, i.e. on
average, 27.9% percent of trials that started reached the finish line to date. In the past 5 years, 103 clinical trials started and 41 clinical trials were completed. i.e. 39.8%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
High-Dose Fluorouracil With or Without Leucovorin Compared With Standard Fluorouracil Plus Leucovorin Following Surgery in Treating Patients With Stage III Colon Cancer
1999-03-01
2007-04-01
Completed
Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
1998-10-01
Active, not recruiting
1,649
Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
1999-04-01
Unknown status
Hormone Therapy With or Without Docetaxel And Estramustine in Treating Patients With Prostate Cancer That is Locally Advanced or At High Risk of Relapse
2002-11-14
2022-12-31
Completed
413
Allogeneic Stem Cell Transplant in Treating Patients With Metastatic Kidney Cancer
2002-11-04
2016-08-17
Completed
57
Efficacy and Safety of Oral Bosentan in Pulmonary Fibrosis Associated With Scleroderma
2003-07-01
2005-09-01
Completed
132
Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Unresectable Pancreatic Adenocarcinoma
2003-11-01
Unknown status
Docetaxel and Epirubicin as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Adenocarcinoma of the Stomach
2001-04-01
Unknown status
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Hôpital Claude Huriez" #1 sponsor was "University Hospital, Lille" with 101 trials, followed by "The Lymphoma Academic Research Organisation" with 27 trials
sponsored, "Celgene" with 24 trials sponsored, "Hoffmann-La Roche" with 15 trials sponsored and "Janssen Research & Development, LLC"
with 15 trials sponsored. Other sponsors include 304 different institutions and
companies that sponsored additional 149 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Hôpital Claude Huriez"
#1 collaborator was "Ministry of Health, France" with 19 trials as a collaborator, "Roche Pharma AG" with 8 trials as a collaborator, "Sanofi" with 7 trials as a collaborator, "AbbVie" with 6 trials as a collaborator and "Bristol-Myers Squibb" with 6 trials as a collaborator. Other collaborators include 183 different institutions and companies that were
collaborators in the rest 142 trials.
Clinical Trials Conditions at Hôpital Claude Huriez
According to Clinical.Site data, the most researched conditions in "Hôpital Claude Huriez" are
"Multiple Myeloma" (38 trials), "Ulcerative Colitis" (17 trials), "Crohn Disease" (11 trials), "Crohn's Disease" (11 trials) and "Lymphoma, Non-Hodgkin" (10 trials). Many other conditions were trialed in "Hôpital Claude Huriez" in a lesser frequency.
Clinical Trials Intervention Types at Hôpital Claude Huriez
Most popular intervention types in "Hôpital Claude Huriez" are "Drug" (318 trials), "Other" (60 trials), "Procedure" (40 trials), "Biological" (31 trials) and "Device" (24 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (61 trials), "Rituximab" (23 trials), "Dexamethasone" (22 trials), "Lenalidomide" (19 trials) and "Obinutuzumab" (11 trials). Other intervention names were less common.
Clinical Trials Genders at Hôpital Claude Huriez
The vast majority of trials in "Hôpital Claude Huriez" are
467 trials for "All" genders, 16 trials for "Male" genders and 7 trials for "Female" genders.
Clinical Trials Status at Hôpital Claude Huriez
Currently, there are NaN active trials in "Hôpital Claude Huriez".
3 are not yet recruiting,
116 are recruiting,
61 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 232 completed trials in Hôpital Claude Huriez,
1 suspended trials,
and 45 terminated clinical trials to date.
Out of the total trials that were conducted in Hôpital Claude Huriez, 46 "Phase 1"
clinical trials were conducted, 161 "Phase 2" clinical
trials and 151 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 10 trials, and there were
also 63 trials that are defined as “Not Applicable".